798 related articles for article (PubMed ID: 30665436)
21. The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial.
Afshar Ebrahimi F; Foroozanfard F; Aghadavod E; Bahmani F; Asemi Z
Biol Trace Elem Res; 2018 Aug; 184(2):300-307. PubMed ID: 29127547
[TBL] [Abstract][Full Text] [Related]
22. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Bahmani F; Karamali M; Shakeri H; Asemi Z
Clin Endocrinol (Oxf); 2014 Oct; 81(4):582-7. PubMed ID: 24628390
[TBL] [Abstract][Full Text] [Related]
23. The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
Raygan F; Ostadmohammadi V; Asemi Z
Clin Nutr; 2019 Aug; 38(4):1594-1598. PubMed ID: 30057015
[TBL] [Abstract][Full Text] [Related]
24. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.
Jamilian M; Shojaei A; Samimi M; Afshar Ebrahimi F; Aghadavod E; Karamali M; Taghizadeh M; Jamilian H; Alaeinasab S; Jafarnejad S; Asemi Z
J Affect Disord; 2018 Mar; 229():41-47. PubMed ID: 29306057
[TBL] [Abstract][Full Text] [Related]
25. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
[TBL] [Abstract][Full Text] [Related]
26. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
27. Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
Jamilian M; Foroozanfard F; Bahmani F; Talaee R; Monavari M; Asemi Z
Biol Trace Elem Res; 2016 Apr; 170(2):271-8. PubMed ID: 26315303
[TBL] [Abstract][Full Text] [Related]
28. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial.
Tamtaji OR; Heidari-Soureshjani R; Mirhosseini N; Kouchaki E; Bahmani F; Aghadavod E; Tajabadi-Ebrahimi M; Asemi Z
Clin Nutr; 2019 Dec; 38(6):2569-2575. PubMed ID: 30642737
[TBL] [Abstract][Full Text] [Related]
29. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Akbari M; Ostadmohammadi V; Lankarani KB; Tabrizi R; Kolahdooz F; Heydari ST; Kavari SH; Mirhosseini N; Mafi A; Dastorani M; Asemi Z
Horm Metab Res; 2018 Apr; 50(4):271-279. PubMed ID: 29475212
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Probiotic Supplementation on Clinical Symptom, Weight Loss, Glycemic Control, Lipid and Hormonal Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
Tabrizi R; Ostadmohammadi V; Akbari M; Lankarani KB; Vakili S; Peymani P; Karamali M; Kolahdooz F; Asemi Z
Probiotics Antimicrob Proteins; 2022 Feb; 14(1):1-14. PubMed ID: 31165401
[TBL] [Abstract][Full Text] [Related]
31. Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.
Vahedpoor Z; Jamilian M; Bahmani F; Aghadavod E; Karamali M; Kashanian M; Asemi Z
Horm Cancer; 2017 Feb; 8(1):58-67. PubMed ID: 28050798
[TBL] [Abstract][Full Text] [Related]
32. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Kouchaki E; Tamtaji OR; Salami M; Bahmani F; Daneshvar Kakhaki R; Akbari E; Tajabadi-Ebrahimi M; Jafari P; Asemi Z
Clin Nutr; 2017 Oct; 36(5):1245-1249. PubMed ID: 27669638
[TBL] [Abstract][Full Text] [Related]
33. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Akkasheh G; Kashani-Poor Z; Tajabadi-Ebrahimi M; Jafari P; Akbari H; Taghizadeh M; Memarzadeh MR; Asemi Z; Esmaillzadeh A
Nutrition; 2016 Mar; 32(3):315-20. PubMed ID: 26706022
[TBL] [Abstract][Full Text] [Related]
34. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
[TBL] [Abstract][Full Text] [Related]
35. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Jamilian H; Jamilian M; Samimi M; Afshar Ebrahimi F; Rahimi M; Bahmani F; Aghababayan S; Kouhi M; Shahabbaspour S; Asemi Z
Gynecol Endocrinol; 2017 Jun; 33(6):442-447. PubMed ID: 28277138
[TBL] [Abstract][Full Text] [Related]
36. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
37. Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Jamilian H; Jamilian M; Foroozanfard F; Afshar Ebrahimi F; Bahmani F; Asemi Z
J Psychosom Obstet Gynaecol; 2018 Dec; 39(4):307-314. PubMed ID: 28980870
[TBL] [Abstract][Full Text] [Related]
38. High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.
Kouchaki E; Afarini M; Abolhassani J; Mirhosseini N; Bahmani F; Masoud SA; Asemi Z
J Nutr; 2018 Aug; 148(8):1380-1386. PubMed ID: 29982544
[TBL] [Abstract][Full Text] [Related]
39. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women.
Asemi Z; Samimi M; Tabassi Z; Shakeri H; Esmaillzadeh A
J Nutr; 2013 Sep; 143(9):1432-8. PubMed ID: 23884390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
